| Offering Information |
| Expected Date | WITHDRAWN |
| Proposed Exchange/Ticker |
Nasdaq: BTRV |
| Security Type |
Common Stock |
| Lead Underwriter |
Piper Jaffray Cos Lazard Capital Markets |
| Days In Registration |
261 |
| Date Filed |
1-Apr-2008 |
| Form Filed | S-1 |
Fundamentals
(Year Ending December 2008) |
| Industry |
Manufacturing |
| Business Description |
Biotrove Inc, headquartered in Woburn, Massachusetts, is a biotechnology company engaged in life science and drug discovery research by leveraging micro- and nano-scale technology with branded technology including OpenArray Genotyping, which provides PCR-based SNP analysis and RapidFire microfluidics technology, which analyze small molecules by mass spectrometry. The company was incorporated in Delaware in February 2000. |
| Revenue |
- |
| Net Income |
- |
| Shares Outstanding (post-offering) |
- |
| Contact |
- |
| Number of Employees |
- |
|
| Original Filing Information |
| US |
| Shares Filed |
- |
| Secondary Shares Filed | - |
| · As a Percent |
- |
| Primary Shares Filed |
- |
| · As a Percent |
- |
| Overallotment Shares Filed |
- |
| File Amount |
- |
| File Price Range |
- - - |
| File Mid Price |
- |
|
